BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 7582848)

  • 21. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology.
    Skacel M; Fahmy M; Brainard JA; Pettay JD; Biscotti CV; Liou LS; Procop GW; Jones JS; Ulchaker J; Zippe CD; Tubbs RR
    J Urol; 2003 Jun; 169(6):2101-5. PubMed ID: 12771727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Value of cytological examination for postoperative bladder cancer].
    Kawachi Y
    Hinyokika Kiyo; 1983 Nov; 29(11):1469-74. PubMed ID: 6677099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: a side-by-side comparison.
    Hautmann S; Toma M; Lorenzo Gomez MF; Friedrich MG; Jaekel T; Michl U; Schroeder GL; Huland H; Juenemann KP; Lokeshwar VB
    Eur Urol; 2004 Oct; 46(4):466-71. PubMed ID: 15363562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The value of urinary cytology in the diagnosis and follow-up of patients with primary bladder tumors].
    Ioiart I; Gurtavenco A; Raica M
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1989; 38(3):173-7. PubMed ID: 2529583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.
    Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M
    Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology.
    Daniely M; Rona R; Kaplan T; Olsfanger S; Elboim L; Freiberger A; Lew S; Leibovitch I
    Cancer; 2007 Dec; 111(6):517-24. PubMed ID: 17963263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Importance of serum and urine CEA determinations in the diagnosis of bladder cancer].
    Adolphs HD; Oehr P
    Helv Chir Acta; 1982 Aug; 49(3-4):307-11. PubMed ID: 7129893
    [No Abstract]   [Full Text] [Related]  

  • 28. [Determination of carcinoembryonic antigen in urine and in gastric secretions].
    Menduni P; Di Sciascio G; Lisanti A; Caracino A
    Minerva Med; 1983 Nov; 74(44):2671-5. PubMed ID: 6657117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Patients with clinically unconfirmed positive urinary cytology --retrospective analysis of clinical courses].
    Kurimura Y; Takahashi A; Hirobe M; Kunishima Y; Masumori N; Matsukawa M; Ito N; Tsukamoto T
    Hinyokika Kiyo; 2007 Jul; 53(7):455-8. PubMed ID: 17702177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urine prothymosin-alpha as novel tumor marker for detection and follow-up of bladder cancer.
    Tzai TS; Tsai YS; Shiau AL; Wu CL; Shieh GS; Tsai HT
    Urology; 2006 Feb; 67(2):294-9. PubMed ID: 16461079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A further study on potential of microsatellite analysis of urine in diagnosis of bladder cancer].
    Zhang J; Zheng S; Di X
    Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(20):1224-6. PubMed ID: 11825522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical significance of urinary CEA measurement as a screening test of bladder cancer (author's transl)].
    Oshiumi Y; Yagi H; Nishitani H; Yamawaki H; Nakayama C; Kamoi I; Matsuura K; Momose S
    Radioisotopes; 1979 Jun; 28(6):367-70. PubMed ID: 531259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunocytochemical study of urine cytological preparations from secondary prostatic adenocarcinoma involving the urinary bladder.
    Mai KT; Ahmed I; Robertson SJ; Belanger EC; Veinot JP; Islam S
    Diagn Cytopathol; 2008 Oct; 36(10):715-20. PubMed ID: 18773445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [ImmunoCyt--a new urine test in diagnosis of bladder cancer].
    Feil G; Bichler KH; Päulgen-Nelde HJ; Hennenlotter J; Zumbrägel A; Stenzl A
    Urologe A; 2003 Apr; 42(4):531-7. PubMed ID: 12715125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary NMP22 BladderChek test in the diagnosis of superficial bladder cancer.
    Moonen PM; Kiemeney LA; Witjes JA
    Eur Urol; 2005 Dec; 48(6):951-6; discussion 956. PubMed ID: 16257108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accuracy of urinary cytology in the diagnosis of primary and recurrent bladder cancer.
    Wiener HG; Vooijs GP; van't Hof-Grootenboer B
    Acta Cytol; 1993; 37(2):163-9. PubMed ID: 8465635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparisons of voided urine cytology, nuclear matrix protein-22 and bladder tumor associated antigen tests for bladder cancer of geriatric male patients in Taiwan, China.
    Tsui KH; Chen SM; Wang TM; Juang HH; Chen CL; Sun GH; Chang PL
    Asian J Androl; 2007 Sep; 9(5):711-5. PubMed ID: 17712491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients.
    Szajda SD; Snarska J; Jankowska A; Roszkowska-Jakimiec W; Puchalski Z; Zwierz K
    Hepatogastroenterology; 2008; 55(82-83):388-93. PubMed ID: 18613372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of urinary cytology for detection of bladder cancer.
    Planz B; Jochims E; Deix T; Caspers HP; Jakse G; Boecking A
    Eur J Surg Oncol; 2005 Apr; 31(3):304-8. PubMed ID: 15780568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Urinary cytology in tumors of the urinary tract].
    Hüsermann M; Sommer E; Blumberg A
    Schweiz Med Wochenschr; 1979 Mar; 109(9):304-8. PubMed ID: 571143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.